Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 1.00 |
| ▸ | TSHR | P16473 | 3/20 | 1.00 |
| ▸ | CYP2A6 | P11509 | 2/20 | 1.00 |
| ▸ | CYP2A13 | Q16696 | 1/20 | 1.00 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.38 |
| ▸ | DRD2 | P14416 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | GAA | P10253 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
| ▸ | CASP1 | P29466 | 1/20 | 0.33 |
| ▸ | CASP7 | P55210 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | NOD2 | Q9HC29 | 1/20 | 0.31 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.31 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Menthofuran SCHEMBL12013745 | 1.00 | ALDH1A1 (1.00) | ALDH1A1TSHRCYP2A6CYP2A13ALOX5 | |
| Menthofuran SCHEMBL113711 | 1.00 | ALDH1A1 (1.00) | ALDH1A1TSHRCYP2A6CYP2A13ALOX5 | |
| SCHEMBL28736052 | 0.86 | ALDH1A1 (0.76) | ALDH1A1TSHRCYP2A6CYP2A13ALOX5 | |
| Menthofuran SCHEMBL23326200 | 0.82 | CYP2A6 (0.67) | ALDH1A1TSHRCYP2A6CYP2A13ALOX5 | |
| SCHEMBL13021597 | 0.70 | — | — | |
| SCHEMBL13021602 | 0.70 | ALDH1A1 (0.53) | ALDH1A1TSHRCYP2A6CYP2A13ALOX5 | |
| SCHEMBL10013879 | 0.64 | ALDH1A1 (0.47) | ALDH1A1TSHRCYP2A6CYP2A13KDM4E | |
| SCHEMBL351647 | 0.64 | ALDH1A1 (0.47) | ALDH1A1TSHRCYP2A6CYP2A13KDM4E | |
| SCHEMBL13931594 | 0.64 | ALDH1A1 (0.47) | ALDH1A1TSHRCYP2A6CYP2A13KDM4E | |
| SCHEMBL12267962 | 0.64 | ALDH1A1 (0.47) | ALDH1A1TSHRCYP2A6CYP2A13KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 264 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12439906-B2 | Pesticide strip, kit, and methods of use | GONZALES JERINA CARMEN (US) | 2025-10-14 | — | — | US | claimed |
| EP-4444108-B1 | ALDEHYDE MIXTURES FOR FLAVOUR IMPROVEMENT | SYMRISE AG (DE) | 2025-09-10 | — | — | EP | claimed |
| EP-4096618-B1 | A MIXTURE COMPRISING 1,2-ALKANEDIOLS | SYMRISE AG (DE) | 2025-01-29 | — | — | EP | claimed |
| EP-3689324-B1 | NEW COOLING AGENTS AND PREPARATIONS COMPRISING THEM | SYMRISE AG (DE) | 2024-11-20 | — | — | EP | claimed |
| EP-4142508-B1 | MINT FLAVOR COMPOSITIONS | PROCTER & GAMBLE (US) | 2024-10-09 | — | — | EP | claimed |
| EP-4438065-A2 | A MIXTURE COMPRISING 1,2-ALKANEDIOLS | Symrise AG (DE) | 2024-10-02 | — | — | EP | claimed |
| US-20240050337-A1 | A MIXTURE COMPRISING 1,2-ALKANEDIOLS | SYMRISE AG (DE) | 2024-02-15 | — | — | US | claimed |
| EP-4161293-B1 | FLAVOURING COMPOSITION WITH BALANCED TASTE PROFILE | SYMRISE AG (DE) | 2024-01-31 | — | — | EP | claimed |
| EP-4161291-B1 | FLAVORING COMPOSITIONS FOR TASTE IMPROVEMENT | SYMRISE AG (DE) | 2023-11-01 | — | — | EP | claimed |
| CN-116490160-A | A mixture containing 1, 2-alkanediol | 西姆莱斯股份公司 | 2023-07-25 | — | — | CN | claimed |
| WO-2016049394-A1 | CLEANING AND/OR TREATMENT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| US-20160089317-A1 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY | 2016-03-31 | — | — | US | claimed |
| US-20160089464-A1 | MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY | 2016-03-31 | — | — | US | claimed |
| WO-2016049395-A1 | PRODUCTS COMPRISING MALODOR REDUCTION MATERIALS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| WO-2016049407-A1 | ABSORBENT ARTICLE COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| US-20160090555-A1 | CLEANING AND/OR TREATMENT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY | 2016-03-31 | — | — | US | claimed |
| US-20160090557-A1 | SUBSTRATES COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY | 2016-03-31 | — | — | US | claimed |
| WO-2016049455-A1 | PERSONAL CARE COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| WO-2016049458-A1 | DELIVERY SYSTEMS COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| WO-2012059763-A1 | BIOMARKERS | THE UNIVERSITY OF MANCHESTER (GB) | 2012-05-10 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160089317-A1 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS | LPO, QDPR, TYR | ALDH1A1 252/4885TSHR 4094/4885CYP2A6 372/4885 |
| US-12439906-B2 | Pesticide strip, kit, and methods of use | ACHE, DDT, PDE1C | ALDH1A1 441/4885TSHR 810/4885CYP2A6 1870/4885 |
| US-20240050337-A1 | A MIXTURE COMPRISING 1,2-ALKANEDIOLS | OR10J3, OR51E2, MAL2 | ALDH1A1 27/4885TSHR 4469/4885CYP2A6 450/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.